24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
AI tools for systematic literature reviews AI can help us to develop high-quality work, including systematic literature reviews (SLRs) for publication. In this article, published in the September edition of The MAP, the official newsletter of the International Society for Medical Publication Professionals, Polly Field, Richard White and Tomas Rees from Oxford PharmaGenesis provide guidance…
A HealthScience approach to integrated evidence generation planning What is an integrated evidence generation plan (IEGP)? An IEGP brings together all evidence generation work, across geographies, to ensure the delivery of robust evidence throughout the product life cycle, helping to improve patient care and outcomes. Why develop an IEGP now? Stakeholder demands for robust and…
Top tips to better understand the accessibility needs and solutions of your audience Why consider accessibility? Without accessibility, a significant proportion of your audience will not be able to read or to understand your materials. Accessibility is particularly important for people who: aren’t familiar with digital formats speak English as a second language have a…
Three top tips for conference posters A conference poster is a fantastic means of communicating your research and showcasing your team. It also serves as a great networking tool, sparking conversations at events and encouraging feedback and follow-up discussions. But sometimes, a poster can fail to generate interest. This can be really disheartening, particularly when…
Three tips for making your communications more omnichannel We conducted a survey of the Medical Affairs community at the MAPS 2024 Americas event and discovered a common theme. We found that many Medical Affairs professionals want to think about content communication in a more omnichannel way. Here are three practical tips to help to create…
Oxford PharmaGenesis welcomes Christopher Rains on board as our first Non-Executive Director Oxford PharmaGenesis is proud to announce the appointment of Christopher Rains as our first Non-Executive Director, strengthening the Board with over 30 years of experience in the pharmaceutical industry. A former executive at Takeda, Shire and AstraZeneca, Chris brings unparalleled knowledge and expertise…
